These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Identification of microRNA signature and potential pathway targets in prostate cancer. Moustafa AA, Ziada M, Elshaikh A, Datta A, Kim H, Moroz K, Srivastav S, Thomas R, Silberstein JL, Moparty K, Salem FE, El-Habit OH, Abdel-Mageed AB. Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835 [Abstract] [Full Text] [Related]
68. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. Ramirez-Garrastacho M, Berge V, Linē A, Llorente A. Br J Cancer; 2022 Feb; 126(3):492-501. PubMed ID: 34811506 [Abstract] [Full Text] [Related]
70. Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions. Maeno A, Terada N, Uegaki M, Goto T, Okada Y, Kobayashi T, Kamba T, Ogawa O, Inoue T. Prostate; 2014 Dec; 74(16):1604-12. PubMed ID: 25176332 [Abstract] [Full Text] [Related]
74. miR-125a-5p expression is associated with the age of breast cancer patients. He H, Xu F, Huang W, Luo SY, Lin YT, Zhang GH, Du Q, Duan RH. Genet Mol Res; 2015 Dec 22; 14(4):17927-33. PubMed ID: 26782438 [Abstract] [Full Text] [Related]
75. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Linē A, Llorente A. Mol Cancer; 2017 Oct 05; 16(1):156. PubMed ID: 28982366 [Abstract] [Full Text] [Related]
76. [Detection and correlation analysis of miRNAs and myeloid-derived suppressor cells in ovarian cancer-bearing mice]. Liu Y, Lin X, Bao T, Ni P, Xie C, Shen H, Xu W, Xu H, Su Z. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr 05; 31(4):467-9, 473. PubMed ID: 25854564 [Abstract] [Full Text] [Related]
77. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer. Pudova EA, Krasnov GS, Nyushko KM, Kobelyatskaya AA, Savvateeva MV, Poloznikov AA, Dolotkazin DR, Klimina KM, Guvatova ZG, Simanovsky SA, Gladysh NS, Tokarev AT, Melnikova NV, Dmitriev AA, Alekseev BY, Kaprin AD, Kiseleva MV, Snezhkina AV, Kudryavtseva AV. BMC Med Genomics; 2020 Sep 18; 13(Suppl 8):129. PubMed ID: 32948204 [Abstract] [Full Text] [Related]
78. MicroRNA expression profiles in human testicular tissues of infertile men with different histopathologic patterns. Abu-Halima M, Backes C, Leidinger P, Keller A, Lubbad AM, Hammadeh M, Meese E. Fertil Steril; 2014 Jan 18; 101(1):78-86.e2. PubMed ID: 24140040 [Abstract] [Full Text] [Related]
79. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic. Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A. Prostate; 2016 Jan 18; 76(1):68-79. PubMed ID: 26417675 [Abstract] [Full Text] [Related]
80. Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens. Peskoe SB, Barber JR, Zheng Q, Meeker AK, De Marzo AM, Platz EA, Lupold SE. BMC Cancer; 2017 Jan 06; 17(1):32. PubMed ID: 28061773 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]